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Purpose: The Seattle Heart Failure Model (SHFM), the Interagency
Registry for Mechanically Assisted Circulatory Support (INTERMACS) and
the Index for Mortality Prediction After Cardiac Transplantation (IMPACT)
score are newly used in heart transplantation for graft allocation. We aimed if
these scores could be useful in risk stratification for cardiac transplantation in
our center. 
Methods: The SHFM, the INTERMACS model and the IMPACT score
were retrospectively calculated for 182 heart transplantation candidates
and 152 non-VAD patients who underwent urgent and non-urgent heart
transplantation between January 2004 and April 2013 in our center.
Results were compared with actual mortality at 1, 2 and 5 years. The per-
formance of these score in predicting hospital mortality was evaluated
with ROC curve.
Results: Predicted mortality at 1, 2 and 5 years with the SHFM score
was significantly higher (p<0.001) in patients who required urgent trans-
plantation. This score was not efficient for predicting waiting list mortality
(AUC= 0,70). A trend toward higher post-transplant mortality at 1, 2 and
5 years was observed in the 1 to 3 INTERMACS class. All patients with
INTERMACS I profile dead after heart transplantation. The IMPACT score
was not efficient in predicting post transplantation mortality in our popula-
tion (AUC = 0,56).
Conclusion: The SHFM should be used to discriminate patients on waiting
list and discuss the degree of required priority. The INTERMACS classifica-
tion appears to be promising tools for heart recipient selection. IMPACT score
seems not adapted to in our population.
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Background: KaRen is a prospective study designed to characterize and
follow a cohort of heart failure with preserved ejection fraction (HFpEF)
patients. HFpEF remains a challenging syndrome. Patients have clinical signs
linked to congestion but left ventricular (LV) EF is > 45%. We sought to test
the relevance of echocardiographic parameters as predictors of death or hospi-
talization for cardiovascular reasons.
Methods and results: Following an acute HF accompanied with NT-
proBNP >300 pg/mL (BNP >100 pg/mL) and LVEF >45%, patients were
included (n=349). The patients were reassessed by echo-Doppler after 4-8
weeks. Echocardiographies were standardized and the analysis centralized.
LVEF was 62±13%, LV global longitudinal strain: – 15±3%, E/e’:12.9±6.2,
Left atrial volume: 49±18ml/m², Tricuspid regurgitation: 2.9±0.9m/s. Two
parameters are correlated with the survival without any death or hospitalisa-
tion for cardiovascular reason and could be combined in a score: 2 x (E / e’)
+ RA area. This score has a theoretical range between 0 and 14. Based on ter-
tiles of the score, censoring (frequencies of death or hospitalization for heart
failure) were 48 (37.80), 67 (57.76) and 85 (75.22) in the 1st tertile – poor
prognosis (N = 127), the 2nd tertile – intermediate (N = 116) and the 3rd ter-
tile – good prognosis (N = 113), respectively.
Conclusion: Combination of simple echocardiographic criteria (right atrial
area and E/e’ ratio) was found relevant to predict the long term prognosis in
a large cohort of patients diagnosed for heart failure with preserved ejection
fraction. 
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Friedreich Ataxia (FRDA) is an autosomal recessive cerebellar ataxia,
caused by GAA expansion in frataxin gene. Hypertrophic cardiomyopathy is
usual in FRDA and cardiac complications are the first cause of death. From
1990 to 2012, we studied 141 patients with genetically confirmed FRDA.
Mean age was 30±10y (mean±sd), 54% were female, age at onset 16±8y,
disease duration 15±8y and 74% were wheelchair users.Mean length of short
GAA expansion was 1,85±0,7Kb and of longer allele 2.6±0.7Kb.Each
patient underwent clinical examination, electrocardiogram and echocardiog-
raphy. 9% had chest pain, 2,8% dyspnea and 9% palpitations. ECG pre-
sented T wave abnormalities (88%). 3 patients had atrial fibrillation
(AF).LV interventricular septal wall thickness (IVS) was 12±3mm, LV pos-
terior wall thickness (PW) =11±2mm, LV diastolic diameter (EDD) =
43±5mm, LV systolic diameter (ESD) =25±5mm and indexed LV mass
(LVMi) =103±31g/m², LV ejection fraction (EF) = 67±7%. News were
obtained in 2013, no patient was lost of follow-up. After a median follow up
of 12±5y, 16 deaths occurred and 1 patient was transplanted (38±10y).
26 patients (18%) experienced AF (34±10y), 14 (10%) heart failure
(36±12y) and 15 (11%) had EF<50% (33±11y). In univariate analysis, the
predictors of survival were: short GAA (p<0.0001), age of onset (p=0.0002),
ESD (p=0.002), IVS (p=0.0087), EF (p=0.0001) and LVMi (p=0.01). In
multivariate analysis, only short GAA (p=0.001), EF (p=0.01) and LVMi
(p=0.008) were independent predictors of survival. Short GAA and LVMi
remained independent predictors of the first cardiac events in multivariate
analysis (p=0.0002, and p=0.0003 respectively). GAA repeats are the best
predictors of survival and cardiac events in FRDA patients, but EF and LV
mass are also predictors of long term evolution suggesting the importance of
cardiac management in Friedreich ataxia.
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Cardiac amyloidosis (CA) is of poor prognosis and has three main causes:
light chain (AL), hereditary (m-TTR) and wild type transthyretin amyloidosis
(WT-TTR). Longitudinal 2D-strain (LS) has been proposed for early diagnosis
of AL-CA with increased LS, indicating less contractility, in basal segments.
LS apical sparing physiopathology and prognosis value are unknown in the
3 types of CA. 
